Group One Trading
BCYC

Group One Trading’s Bicycle Therapeutics BCYC Stock Holding History

Group One Trading’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.6K Buy
4,000
+3,500
+700% +$20K ﹤0.01% 6014
2025
Q4 		$3.54K Sell
500
-100
-17% -$737 ﹤0.01% 7332
2025
Q3 		$4.64K Hold
600
– – ﹤0.01% 7580
2025
Q2 		$4.17K Sell
600
-300
-33% -$2.39K ﹤0.01% 7156
2025
Q1 		$7.64K Buy
900
+600
+200% +$7.07K ﹤0.01% 6423
2024
Q4 		$4.2K Hold
300
– – ﹤0.01% 6484
2024
Q3 		$6.79K Buy
+300
New +$6.92K ﹤0.01% 5766
2024
Q2 		– Sell
-2,000
Closed -$49.8K – 6719
2024
Q1 		$49.8K Sell
2,000
-16,100
-89% -$342K ﹤0.01% 4728
2023
Q4 		$327K Sell
18,100
-32,100
-64% -$531K ﹤0.01% 3441
2023
Q3 		$1.01M Sell
50,200
-37,500
-43% -$858K ﹤0.01% 2266
2023
Q2 		$2.24M Buy
87,700
+49,100
+127% +$1.14M 0.01% 1604
2023
Q1 		$821K Hold
38,600
– – ﹤0.01% 2304
2022
Q4 		$1.14M Buy
+38,600
New +$1.04M ﹤0.01% 2295

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Group One Trading's BCYC Position: Q3 2025 in Review

Group One Trading sold out of Bicycle Therapeutics (BCYC) in Q3 2025, closing a stake of 1,294 shares — an estimated $9.77K sold.

Group One Trading first reported a position in BCYC in Q4 2022 and held it in 9 quarters. The position peaked at $2.14M in Q2 2023. 99 funds tracked by Wall St. Rank hold BCYC as of Q3 2025.

  • Group One Trading reported no remaining Bicycle Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 1,294 Bicycle Therapeutics shares in Q3 2025, an estimated $9.77K.
  • Group One Trading first reported a position in Bicycle Therapeutics in Q4 2022 and held it in 9 quarters.
  • Group One Trading's Bicycle Therapeutics position peaked at $2.14M in Q2 2023.
  • 99 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.